CovidChloroV1, Main, Corpus, bibRecord, 001651

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.

Identifieur interne : 001651 ( Main/Corpus ); précédent : 001650; suivant : 001652

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.

Auteurs : Vasilios M. Polymeropoulos

Source :

Frontiers in medicine [ 2296-858X ] ; 2020.

RBID : pubmed:32426364
DOI: 10.3389/fmed.2020.00192
PubMed: 32426364
PubMed Central: PMC7203551

Links to Exploration step

pubmed:32426364

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.</title>
<author><name sortKey="Polymeropoulos, Vasilios M" sort="Polymeropoulos, Vasilios M" uniqKey="Polymeropoulos V" first="Vasilios M" last="Polymeropoulos">Vasilios M. Polymeropoulos</name>
<affiliation><nlm:affiliation>Vanda Pharmaceuticals, Washington, DC, United States.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32426364</idno>
<idno type="pmid">32426364</idno>
<idno type="doi">10.3389/fmed.2020.00192</idno>
<idno type="pmc">PMC7203551</idno>
<idno type="wicri:Area/Main/Corpus">001651</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001651</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.</title>
<author><name sortKey="Polymeropoulos, Vasilios M" sort="Polymeropoulos, Vasilios M" uniqKey="Polymeropoulos V" first="Vasilios M" last="Polymeropoulos">Vasilios M. Polymeropoulos</name>
<affiliation><nlm:affiliation>Vanda Pharmaceuticals, Washington, DC, United States.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in medicine</title>
<idno type="ISSN">2296-858X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32426364</PMID>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>7</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in medicine</Title>
<ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation>
</Journal>
<ArticleTitle>Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>192</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2020.00192</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Polymeropoulos</LastName>
<ForeName>Vasilios M</ForeName>
<Initials>VM</Initials>
<AffiliationInfo><Affiliation>Vanda Pharmaceuticals, Washington, DC, United States.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Front Med (Lausanne)</MedlineTA>
<NlmUniqueID>101648047</NlmUniqueID>
<ISSNLinking>2296-858X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">chloroquine</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>5</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32426364</ArticleId>
<ArticleId IdType="doi">10.3389/fmed.2020.00192</ArticleId>
<ArticleId IdType="pmc">PMC7203551</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32164085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2013 Feb;23(2):300-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23208422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Mar 09;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 2009 Aug;53(8):3416-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19506054</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Pharmacol. 1989 Jun;27(6):771-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2757893</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2002 Nov 1;35(9):1071-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12398064</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001651 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001651 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32426364
   |texte=   Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32426364" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.

Hydroxychloroquine: A Familiar Agent to Combat the Pandemic of COVID-19.

Source :

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki